liver disease mash - Search News

News

Wegovy, liver disease

Fox News on MSN · 1d

Semaglutide found to have shocking benefit for liver disease patients in new study

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

The New York Times · 3d

Wegovy Could Treat Another Chronic Disease

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Everyday Health on MSN · 2d

Wegovy May Halt and Even Reverse Severe Liver Disease

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver disease MASH.

Fierce Pharma2d

Madrigal's Rezdiffra, the first-ever MASH drug, beats sales projections for 4 quarters in a row

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

Semaglutide tied to significant improvements in MASH, liver fibrosis at 72 weeks

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results